$EWTX

$39.53 +$0.36 (0.92%) Close

$EWTX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 108.6M shares outstanding

Who owns EWTX?

By type of holder

Institutions 100.0% Insiders 0.0% Everyone else 0.0%

Concentration Top 10 holders own 74.5%

Orbimed Advisors LLC 14.3% · Orbimed Capital GP Vi LLC 13.6%

Institutional ownership

100.0%

0 pts vs last qtr

Institutional holders

225

+11 vs last qtr

Net shares bought

+656.1K

by institutions in Q2 2026

New / sold out

42 / 31

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Jupiter Topco LLC NEW +6.1M
FMR LLC +4.5M

Biggest sellers in Q2 2026

Janus Henderson Group PLC SOLD OUT −5.9M
Baker Bros. Advisors LP −2.9M

Who is planning to sell?

Notices of proposed sale, last 12 months

$32.1M

10 notices from 4 people

Shares covered

1.1M

1.00% of the company

Arranged in advance

48%

of the value is under a 10b5-1 plan

Under a 10b5-1 plan No plan

Largest proposed sellers

Robert Michael Carruthers Officer $14.6M
Alan J Russell Director $10.2M

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2020–FY2025

+13828.3%

+168.40% a year

Each share's claim on the business

−99.3%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $92.7M

over 6 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years41% 3–5 years8% 1–3 years42% Under 1 year10%

Quarterly turnover

18.0%

of institutional shares changed hands

Top 10 managers, median time held

2.5 years

Super Investors

Investment managers reporting EWTX on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
OA Orbimed Advisors LLC 13D · 14.5%	15.5M	14.29%	Unchanged	≤2021	11.7%
Shares held by quarter Peak holding15.5M (Q2'25) Change over 8 quarters+496.8K Share of the company14.290% Disclosed stake13D · 14.5% Orbimed Advisors LLC's full portfolio →
RC Ra Capital Management, L.P.	8.4M	7.73%	−2.0M (−19.5%)	2024	3.0%
Shares held by quarter Peak holding10.4M (Q3'25) Change over 8 quarters−516.4K Share of the company7.730% Ra Capital Management, L.P.'s full portfolio →

Orbimed Advisors LLC

13D · 14.5%

15.5M

% of company

14.29%

Change vs last qtr

Unchanged

Held since

≤2021

Ra Capital Management, L.P.

8.4M

% of company

7.73%

Change vs last qtr

−2.0M (−19.5%)

Held since

2024

28 more super investors behind a free account

See every manager holding Edgewise Therapeutics, Inc., how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting EWTX on Form N-PORT; together they hold 24.0% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$118M	2.9M	2.67%	0.01%	June 30, 2026
IR iShares Russell 2000 ETF iShares Trust	$74.6M	1.8M	1.69%	0.09%	June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$118M

% of company

2.67%

% of the fund

0.01%

As of

June 30, 2026

iShares Russell 2000 ETF

iShares Trust

Position value

$74.6M

% of company

1.69%

% of the fund

0.09%

As of

June 30, 2026

23 more funds behind a free account

See every fund holding Edgewise Therapeutics, Inc. and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
OC Orbimed Capital GP Vi LLC 5%+ holder 13D · 14.1%	14.8M	13.64%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company13.640% Disclosed stake13D · 14.1% View the 13D/G filing →
TP Thompson Peter A Insider	763.4K	0.70%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.700% Thompson Peter A's insider activity →

Orbimed Capital GP Vi LLC

5%+ holder13D · 14.1%

14.8M

% of company

13.64%

Change vs last qtr

—

Held since

—

Thompson Peter A

Insider

763.4K

% of company

0.70%

Change vs last qtr

—

Held since

—

11 more holders behind a free account

See every insider and 5%+ holder of Edgewise Therapeutics, Inc..

Comments